Evidence map›Paper›PMID 33687501›Full record

ArticleCellular and molecular life sciences : CMLS2021

R-catcher, a potent molecular tool to unveil the arginylome.

Taewook Seo, Jihyo Kim, Ho-Chul Shin, Jung Gi Kim, Shinyeong Ju, Laxman Nawale, Goeun Han, Hye Seon Lee, Geul Bang, Jin Young Kim and 8 more

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Designing the Proteome with Chemical Tools: Degrons and Beyond.Chembiochem : a European journal of chemical biology · 2025
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. N-Terminal Arginylation Pull-down Analysis Using the R-Catcher Tool.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 1 country.

Taewook SeoAnticancer Agent Research Center, Korea Research Institute of Bioscience and Biotechnology, Ochang-eup, Cheongju-si, Chungcheongbuk-do, 28116, Republic of Korea.
Jihyo KimAnticancer Agent Research Center, Korea Research Institute of Bioscience and Biotechnology, Ochang-eup, Cheongju-si, Chungcheongbuk-do, 28116, Republic of Korea.
Ho-Chul ShinDisease Target Structure Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, 34141, Republic of Korea.
Jung Gi KimAnticancer Agent Research Center, Korea Research Institute of Bioscience and Biotechnology, Ochang-eup, Cheongju-si, Chungcheongbuk-do, 28116, Republic of Korea.
Shinyeong JuCenter for Theragnosis, Korea Institute of Science and Technology, Seoul, 02792, Republic of Korea.
Laxman NawaleAnticancer Agent Research Center, Korea Research Institute of Bioscience and Biotechnology, Ochang-eup, Cheongju-si, Chungcheongbuk-do, 28116, Republic of Korea.
Goeun HanAnticancer Agent Research Center, Korea Research Institute of Bioscience and Biotechnology, Ochang-eup, Cheongju-si, Chungcheongbuk-do, 28116, Republic of Korea.
Hye Seon LeeDisease Target Structure Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, 34141, Republic of Korea.
Geul BangResearch Center for Bioconvergence Analysis, Korea Basic Science Institute, Ochang, 28116, Republic of Korea.
Jin Young KimResearch Center for Bioconvergence Analysis, Korea Basic Science Institute, Ochang, 28116, Republic of Korea.
Jeong Kyu BangDivision of Magnetic Resonance, Korea Basic Science Institute, Ochang, 28116, Republic of Korea.
Kyung Ho LeeAnticancer Agent Research Center, Korea Research Institute of Bioscience and Biotechnology, Ochang-eup, Cheongju-si, Chungcheongbuk-do, 28116, Republic of Korea.
Nak-Kyun SoungAnticancer Agent Research Center, Korea Research Institute of Bioscience and Biotechnology, Ochang-eup, Cheongju-si, Chungcheongbuk-do, 28116, Republic of Korea.
Joonsung HwangAnticancer Agent Research Center, Korea Research Institute of Bioscience and Biotechnology, Ochang-eup, Cheongju-si, Chungcheongbuk-do, 28116, Republic of Korea.
Cheolju LeeCenter for Theragnosis, Korea Institute of Science and Technology, Seoul, 02792, Republic of Korea.
Seung Jun KimDepartment of Biomolecular Science, KRIBB School, University of Science and Technology, Daejeon, 34113, Republic of Korea. ksj@kribb.re.kr.
Bo Yeon KimAnticancer Agent Research Center, Korea Research Institute of Bioscience and Biotechnology, Ochang-eup, Cheongju-si, Chungcheongbuk-do, 28116, Republic of Korea. bykim@kribb.re.kr.
Hyunjoo Cha-MolstadAnticancer Agent Research Center, Korea Research Institute of Bioscience and Biotechnology, Ochang-eup, Cheongju-si, Chungcheongbuk-do, 28116, Republic of Korea. hcha@kribb.re.kr.ORCID http://orcid.org/0000-0003-3676-7150
Korea Research Institute of Bioscience and Biotechnology · KRKorea Basic Science Institute · KRKyung Hee University · KR

Funding

Ministry of Science, ICT and Future Planning 2020R1A2C1010512National Research Council of Science and Technology CAP-16-03-LROBBNational Research Foundation of Korea 2020R1A2C2003685
6 · The paper itself

Abstract

Protein arginylation is a critical regulator of a variety of biological processes. The ability to uncover the global arginylation pattern and its associated signaling pathways would enable us to identify novel disease targets. Here, we report the development of a tool able to capture the N-terminal arginylome. This tool, termed R-catcher, is based on the ZZ domain of p62, which was previously shown to bind N-terminally arginylated proteins. Mutating the ZZ domain enhanced its binding specificity and affinity for Nt-Arg. R-catcher pulldown coupled to LC-MS/MS led to the identification of 59 known and putative arginylated proteins. Among these were a subgroup of novel ATE1-dependent arginylated ER proteins that are linked to diverse biological pathways, including cellular senescence and vesicle-mediated transport as well as diseases, such as Amyotrophic Lateral Sclerosis and Alzheimer's disease. This study presents the first molecular tool that allows the unbiased identification of arginylated proteins, thereby unlocking the arginylome and provide a new path to disease biomarker discovery.

Indexed as

Protein Processing, Post-TranslationalAminoacyltransferasesArginineEndoplasmic ReticulumGenetic VectorsHeLa CellsHumansMembrane ProteinsSubstrate SpecificityAminoacyltransferasesArginineMembrane ProteinsATE1 R-transferaseBaitCLUSExtracellular exosomeFBLN1Innate Immune SystemOvarian cancerPRDX4Prostate cancerSERPINH1Unfolded Protein Response

Identifiers

PMID33687501
PMCPMC8038991
OpenAlexW3135804860

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.